tirzepatide program 12-Week Tirzepatide (Mounjaro®) Weight Management Program

Expect your doctor to discuss a gradual dose escalation, typically starting low and increasing every 4 weeks to allow your body to adapt

One proposed mechanism involves GLP-1 receptors in the hypothalamus and pituitary gland

Most recently, a 2022 study indicates that GLP-1 analogues are associated with a higher chance of gallbladder disease

If you are using an injectable format, the needles are typically very small (similar to those used by people with diabetes) and the injection is done into the fatty tissue of the stomach, thigh, or upper arm

Dose increases are recommended only if weight loss plateaus or stops, indicating that your metabolic adaptation requires stronger receptor activation